Compounds > 1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol

1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol and dizocilpine

1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol has been researched along with dizocilpine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, WB; Dingledine, R; Easterling, K; French, A; Geballe, M; Gruszecka-Kowalik, E; Irier, H; Kotloski, R; Le, P; Liotta, DC; Lyuboslavsky, P; McNamara, JO; Myers, SJ; Snyder, JP; Tahirovic, YA; Traynelis, SF; Wilson, LJ; Yuan, H1

Other Studies

1 other study(ies) available for 1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol and dizocilpine

ArticleYear
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
    Journal of medicinal chemistry, 2008, Sep-25, Volume: 51, Issue:18

    Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Excitatory Amino Acid Antagonists; Magnetic Resonance Spectroscopy; Mass Spectrometry; Motor Activity; Propanolamines; Rats; Receptors, N-Methyl-D-Aspartate; Stereoisomerism; Structure-Activity Relationship; Xenopus

2008